/daily ·17 AUG 2026 ·MONDAY ·1 MIN READ ·4 STORIES

Brains, Exomes and a Cocktail

A Monday of large numbers and small print: 258 autopsied brains reopening the hormone-therapy question, a million exomes pointing at one metabolic gene, and a mouse cocktail with a suspiciously precise survival figure.

01 / The Day

MONDAY 17 AUG 2026, ranked

Estrogen-only therapy linked to less Alzheimer's pathology

A Stanford-led analysis of 21,462 women, published in Neurology, reports that estrogen-only menopausal hormone therapy was associated with lower odds of a dementia diagnosis and of Alzheimer's pathology found at autopsy. Association only, and the users were an unusual group by construction.

39% lower odds of clinical dementia, 35% lower odds of pathology at autopsy
258 estrogen-only brains compared with 2,701 from women reporting no therapy
Estrogen-only regimens follow hysterectomy, so users are not a random sample

Why it mattersIt is the first look inside autopsied brains at a question two decades of observational data left unsettled.

01 med.stanford.edu↗

One million exomes point to FNIP1 as a metabolic brake

Ultra-rare protein-truncating variants in FNIP1, at an allele frequency of about 0.01%, tracked with lower liver fat, lower glycaemia and a better lipid profile. The gene encodes a suppressor of energy expenditure, so losing it appears to shift metabolism in a favourable direction.

1,032,116 exomes analysed across eleven cohorts in America, Europe and Asia
Carriers had ~60% lower odds of a composite cardiometabolic outcome (OR 0.39)
Of 59 genes flagged overall, 23 encode approved or clinical-stage drug targets

Why it mattersHuman loss-of-function carriers are the closest thing metabolism has to a natural experiment in switching a target off.

02 nature.com↗

Senescence spreads between brain cells, and it has a direction

A Stony Brook group profiled five human brain cell types to work out which ones broadcast senescence-associated signals and which receive them. Astrocytes and microglia drove the spread; conditioned media pushed neither neurons nor oligodendrocytes into senescence.

Astrocytes, microglia, endothelial cells, oligodendrocytes and neurons profiled
CCL2, MIF, CXCR7 and DPP4 emerged as candidate transmission choke points
Cell-culture work using conditioned media, not intact brain tissue or animals

Why it mattersIt reframes brain senescence as a transmission problem with identifiable targets rather than a simple cell-count problem.

03 onlinelibrary.wiley.com↗

Myasthenia gravis patients outlive the general population

Death-certificate data from four US states found people with myasthenia gravis died on average 4.8 years later than the general population, while multiple sclerosis patients died 12.4 years earlier. The authors label it hypothesis-generating and appear to mean it.

Florida, Wisconsin, Texas and New York, for 2000, 2005, 2010 and 2015
The MG cohort outlived the MS cohort by 15.5 years
No data on onset age, severity or treatment; age at death, not survival time

Why it mattersAn autoimmune disease that correlates with living longer is either a data artefact or a lead nobody has chased properly.

04 journals.sagepub.com↗

Be subscriber #013 the weekly ten, every friday by email · no spam · unsubscribe anytime

Past days

The Daily Archive

/MON 17 AUGBrains, Exomes and a Cocktail /FRI 14 AUGWhat the Clocks Are Actually Measuring /WED 12 AUGInflammation, isolation, and the stem cells in your gut /MON 10 AUG350 papers on protein, 20 clinical trials, and a ceiling made of DNA /FRI 07 AUGFirst mRNA flu vaccine; tau finds a second way to harm /WED 05 AUGSenolytics, centenarian microbes, and a protein that poisons aging brains /MON 03 AUGProtein, lifespan ceilings, and uneven clocks /FRI 31 JULBlood proteins predict liver disease 16 years early /WED 29 JULWednesday, 29 July — Clocks, guts, heat /MON 27 JULFDA Splits the Peptide Vote, Salk Finds Zombie Cells' Weakness, and GBD Says Healthy Years Aren't Keeping Pace /FRI 24 JULThe Drug That Lost Its Heart /WED 22 JULBlood, bone, and the morbidity gap /FRI 17 JULFriday in Longevity: Clocks, Fat, and Immune Decay /WED 15 JULSenescent terrain /MON 13 JULLecanemab under the skin /FRI 10 JULLongevity | Jul 10 2026: Gut, Senescence, Epigenetics /WED 08 JULDrugs remapped to aging hallmarks, ovarian aging reversed, and a 50% molecular gap /MON 06 JULCentenarian chemistry, sleeping circuits, and reprogrammed eyes /FRI 03 JULOvaries, progenitors, and oxygen /WED 01 JULTelomere signals, proteomic clocks, and faster biological aging /MON 29 JUNMonday, June 29 — Longevity